Sichuan Kelun Pharmaceutical Co Ltd (002422) — Cash Flow Reinvestment Rate
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥393.58 Million (capex CN¥393.58 Million ) from operating cash flow of CN¥537.31 Million. Explore Sichuan Kelun Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. Also explore 002422 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Sichuan Kelun Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Sichuan Kelun Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.94 Billion | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +84.5% |
| 2024 | 0.40x | CN¥1.78 Billion | CN¥4.49 Billion | CN¥1.68 Billion | ▼ -58.8% |
| 2023 | 0.96x | CN¥5.14 Billion | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +71.8% |
| 2022 | 0.56x | CN¥1.75 Billion | CN¥3.13 Billion | CN¥896.02 Million | ▲ +1.7% |
| 2021 | 0.55x | CN¥1.57 Billion | CN¥2.85 Billion | CN¥990.56 Million | ▼ -24.1% |
| 2020 | 0.73x | CN¥1.61 Billion | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -2.4% |
| 2019 | 0.74x | CN¥1.65 Billion | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +34.5% |
| 2018 | 0.55x | CN¥1.63 Billion | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -71.7% |
| 2017 | 1.95x | CN¥2.35 Billion | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +86.4% |
| 2016 | 1.05x | CN¥1.81 Billion | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -40.4% |
| 2015 | 1.76x | CN¥2.18 Billion | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -22.3% |
| 2014 | 2.26x | CN¥2.76 Billion | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥2.26 Billion | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥2.77 Billion | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥2.00 Billion | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥647.22 Million | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥275.29 Million | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥226.58 Million | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥175.05 Million | CN¥168.42 Million | CN¥175.05 Million | — |